Development, Commercialization and Licensing Agreement Sample Contracts

AMENDMENT NO. 1 TO DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT

Development, Commercialization and Licensing Agreement • May 15th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Delaware

• Contract Type
  Development, Commercialization and Licensing Agreement
• Filed
  May 15th, 2009
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Delaware

This AMENDMENT NO. 1 TO DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT (“Amendment”) is made and effective as of May 14, 2007, by and between Laboratory Corporation of America Holdings (“LabCorp”) and ARCA Discovery, Inc. (“ARCA”).

AMENDMENT NO. 2 TO DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT

Development, Commercialization and Licensing Agreement • May 15th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Delaware

• Contract Type
  Development, Commercialization and Licensing Agreement
• Filed
  May 15th, 2009
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Delaware

This Amendment No. 2 to Development, Commercialization and Licensing Agreement (the “Amendment”) is made and effective as of May , 2008, by and between Laboratory Corporation of America Holdings (“LabCorp”) and ARCA Discovery, Inc. (“ARCA”).

DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT BETWEEN ARCA DISCOVERY, INC. AND LABORATORY CORPORATION OF AMERICA HOLDINGS DATED FEBRUARY 1, 2007

Development, Commercialization and Licensing Agreement • November 6th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Development, Commercialization and Licensing Agreement
• Filed
  November 6th, 2009
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Development, Commercialization and Licensing Agreement (this “Agreement”) is made and entered into as of February 1, 2007 (the “Effective Date”) between ARCA Discovery, Inc., a Delaware corporation (hereinafter “ARCA”), and Laboratory Corporation of America Holdings, a Delaware corporation (hereinafter “LabCorp”).

DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT BETWEEN ARCA DISCOVERY, INC. AND LABORATORY CORPORATION OF AMERICA HOLDINGS DATED FEBRUARY 1, 2007

Development, Commercialization and Licensing Agreement • May 15th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Development, Commercialization and Licensing Agreement
• Filed
  May 15th, 2009
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Development, Commercialization and Licensing Agreement (this “Agreement”) is made and entered into as of February 1, 2007 (the “Effective Date”) between ARCA Discovery, Inc., a Delaware corporation (hereinafter “ARCA”), and Laboratory Corporation of America Holdings, a Delaware corporation (hereinafter “LabCorp”).